[[(R)-2-[(2S)-2-[[[4-[(ヒドロキシアミノ)(イミノ)メチル]ベンジル]アミノ]カルボニル]アゼチジン-1-イル]-2-オキソ-1-シクロヘキシルエチル]アミノ]酢酸エチル 化学特性,用途語,生産方法
説明
Ximelagatran (XII), a prodrug of a direct thrombin
inhibitor, melagatrin, was approved in the European Union
in December, 2003, for the prevention of venous
thromboembolic events in patients undergoing major
elective orthopedic surgery, that is, hip or knee replacement. The FDA, however, did not approve the drug in the
US based on the recommendation of the advisory panel.
使用
Antithrombotic agent.
[[(R)-2-[(2S)-2-[[[4-[(ヒドロキシアミノ)(イミノ)メチル]ベンジル]アミノ]カルボニル]アゼチジン-1-イル]-2-オキソ-1-シクロヘキシルエチル]アミノ]酢酸エチル 上流と下流の製品情報
原材料
準備製品